438 related articles for article (PubMed ID: 26895288)
41. New anti-cancer strategies: epigenetic therapies and biomarkers.
Balch C; Montgomery JS; Paik HI; Kim S; Kim S; Huang TH; Nephew KP
Front Biosci; 2005 May; 10():1897-931. PubMed ID: 15769674
[TBL] [Abstract][Full Text] [Related]
42. Histone post-translational modification: from discovery to the clinic.
Thomas NR
IDrugs; 2006 Jun; 9(6):398-401. PubMed ID: 16752306
[No Abstract] [Full Text] [Related]
43. The potential role of epigenetic therapy in multiple myeloma.
Smith EM; Boyd K; Davies FE
Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic chemical probes.
Müller S; Brown PJ
Clin Pharmacol Ther; 2012 Dec; 92(6):689-93. PubMed ID: 23093316
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer.
Liu W; Cui Y; Ren W; Irudayaraj J
Clin Epigenetics; 2019 Jan; 11(1):16. PubMed ID: 30700309
[TBL] [Abstract][Full Text] [Related]
46. EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer.
Chen Y; Zhu H; Luo Y; Tong S; Liu Y
Biomed Pharmacother; 2024 Jun; 175():116624. PubMed ID: 38670045
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic targeting in pancreatic cancer.
van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
[TBL] [Abstract][Full Text] [Related]
48. [The epigenetic alteration and the effect of HDAC inhibitors in multiple myeloma].
Terui Y
Nihon Rinsho; 2015 Jan; 73(1):124-9. PubMed ID: 25626317
[TBL] [Abstract][Full Text] [Related]
49. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
50. HDAC modulation and cell death in the clinic.
Dell'Aversana C; Lepore I; Altucci L
Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic Modulators as Therapeutic Agents in Cancer.
Patnaik E; Madu C; Lu Y
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834411
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360879
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic regulation and cancer (review).
Chen QW; Zhu XY; Li YY; Meng ZQ
Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
[TBL] [Abstract][Full Text] [Related]
54. Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program.
Hirukawa A; Smith HW; Zuo D; Dufour CR; Savage P; Bertos N; Johnson RM; Bui T; Bourque G; Basik M; Giguère V; Park M; Muller WJ
Nat Commun; 2018 Jun; 9(1):2547. PubMed ID: 29959321
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic therapy for breast cancer.
Cai FF; Kohler C; Zhang B; Wang MH; Chen WJ; Zhong XY
Int J Mol Sci; 2011; 12(7):4465-87. PubMed ID: 21845090
[TBL] [Abstract][Full Text] [Related]
56. Epigenetics in Personalized Management of Lung Cancer.
Ahmad A
Adv Exp Med Biol; 2016; 890():111-22. PubMed ID: 26703801
[TBL] [Abstract][Full Text] [Related]
57. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
58. Histone deacetylase inhibitors: anticancer compounds.
Smith KT; Workman JL
Int J Biochem Cell Biol; 2009 Jan; 41(1):21-5. PubMed ID: 18845268
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response.
Pathiraja TN; Stearns V; Oesterreich S
J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):35-47. PubMed ID: 20101445
[TBL] [Abstract][Full Text] [Related]
60. Histone deacetylases and epigenetic therapies of hematological malignancies.
Mercurio C; Minucci S; Pelicci PG
Pharmacol Res; 2010 Jul; 62(1):18-34. PubMed ID: 20219679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]